Fig. 4From: Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trialKaplan–Meier curve for maintenance of low disease activity. Curves indicate loss of low disease activity over 24 weeks in relation to the treatment arms (blue: switching to tacrolimus; black: continuing TNFi). MTX, methotrexate; TAC, tacrolimus; TNFi, tumor necrosis factor inhibitorBack to article page